Tradestie Institutional Equity Comparison Engine
GNPX vs NVS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NVS Overall Edge
NVS Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Novartis AG (NVS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, GNPX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NVS at 15.2x Forward P/E and 34.0% operating margin (+4.7% YoY). In options structure, GNPX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
NVS
GNPX N/M vs NVS 15.2x Fwd P/E
Growth & Margin Winner
NVS
Op Margin 0.0% vs 34.0% ยท YoY +0.0% vs +4.7%
Momentum & Technical Winner
NVS
1Y -56.6% vs +18.2% ยท 52W Pos 11% vs 58%
Options & Structure Winner
NVS
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (6th %ile IV)
GNPX
NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap
$2.2M
1M Return
-26.77%
1Y Return
-56.59%
Forward P/E
N/M
Unified AI Score
42.2 / 100
HOLD
Tech 25.0
Fund 47.0
Flow 50.0
Mom 59.0
NVS
NYSE
Novartis AG
Pharmaceutical Preparations
$150.47
-0.5% 1D
Market Cap
$285.6B
1M Return
-3.71%
1Y Return
+18.19%
Forward P/E
15.2x
Unified AI Score
37.0 / 100
SELL
Tech 20.0
Fund 34.0
Flow 50.0
Mom 36.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
GNPX -56.59%
NVS +18.19%
Spread: +74.78 pp (NVS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
GNPX TTM Op. Margin: 0.0%
NVS TTM Op. Margin: 34.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNPX vs NVS. Trailing 12-month operating profitability (GNPX 0.0% vs NVS 34.0%) and valuation multiples (GNPX N/M vs NVS 15.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GNPX | NVS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.2M | $285.6B | Larger Scale | NVS |
| Trailing P/E Ratio Valuation | N/M | 28.9x | Lower Multiple | NVS |
| Forward P/E Ratio Valuation | N/M | 15.2x | Lower Multiple | NVS |
| Revenue Growth (YoY) Growth | +0.0% | +4.7% | Higher Growth | NVS |
| Operating Margin (TTM) Profitability | 0.0% | 34.0% | Higher Margin | NVS |
| Net Profit Margin Profitability | 0.0% | 17.5% | Higher Margin | NVS |
| Return on Equity (ROE) Capital Efficiency | -233.7% | 24.3% | Higher ROE | NVS |
| 52-Week Range Position Momentum | 11% ($0โ$10) | 58% ($123โ$170) | Stronger Trend | NVS |
| Beta / 30D Volatility Risk Regime | -4.68ฮฒ ยท 96% Vol | 0.32ฮฒ ยท 28% Vol | Lower Realized Risk | NVS |
| Unified Institutional Score Composite Signal | 42.2 / 100 (HOLD) | 37.0 / 100 (SELL) | Higher Composite | GNPX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full GNPX vs NVS Buy Guide
GNPX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NVS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither GNPX nor NVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.